High prevalence and no latitude gradient of multiple sclerosis in Norway

Berg‐Hansen, Pål; Moen, Stine Marit; Hf, Harbo; Celius, E. G.

doi:10.1177/1352458514525871

Cited by 46 publications

(57 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The prevalence rate of 211/100 000 inhabitants was higher than a recent prevalence report of 186/100 000 in Western Norway. 9 These diverging results are most likely a result of the limitation of using data from the National Patients Registry included in this recent nationwide study. 9 Previous Norwegian studies using hospital records (as in our study) have reported MS prevalence rates of 170/100 000 in the south-eastern county of Oslo, 10 180/100 000 in the southern county of Vest-Agder 7 and 185.6/100 000 in the eastern county of Oppland.…”

Section: Discussionmentioning

confidence: 76%

“…9 These diverging results are most likely a result of the limitation of using data from the National Patients Registry included in this recent nationwide study. 9 Previous Norwegian studies using hospital records (as in our study) have reported MS prevalence rates of 170/100 000 in the south-eastern county of Oslo, 10 180/100 000 in the southern county of Vest-Agder 7 and 185.6/100 000 in the eastern county of Oppland. 8 The prevalence rate in Hordaland was, thus, similar to the latest report from the UK, 11 sample collection termination day, in order to calculate the valid prevalence.…”

Section: Discussionmentioning

confidence: 76%

“…20 . 9 We showed relatively stable incidence rates during the past three decades. However, since we reported the year-ofonset incidence, we observed a drop in rate probably due to delayed diagnosed cases for the latest 5-year period.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Prevalence of Multiple Sclerosis in Saudi Arabia

Alshanqiti¹,

Alotaibi²,

Alahmed³

et al. 2016

IJAR

View full text Add to dashboard Cite

This study aimed at detecting a rough estimation of the prevalence of multiple sclerosis among citizens of Saudi Arabia. Methodology:It is a cross sectional study purposed to estimate the prevalence of multiple sclerosis in KSA in 2016. It involved 633 individual from the society of Saudi Arabia. Results and conclusion:Most of the respondents (68.1%)were female, Also most of them (47.1%) aged between (20-24) , (94.5%) of them were Saudi national, the largest proportion of them (34.4%) live in the eastern region, (69.8%) of them hold a university degree, and (57.7%) of the respondents are single. Also, we found out that (66.2%) of the respondents don't know if they have MS or not, while (64.1%) of them don't have relatives suffer from MS, as (24.3%) of the relatives who suffer from MS were cousins, and the most common suspicious symptom of MS was Fatigue Exhaustion as (6.8%) of the respondents have that symptom, also (96.4%) of the respondents don't suffer from immune diseases, and most of those who suffer from immune diseases (26.1%) suffer from eczema. Also, (86.1%) of the respondents don't suffer from Genetics diseases, while(18.2%) of the respondents who suffer from Genetic disease suffer from diabetes, and (71.7) of the respondents who suffer MS are females, while 49.1%) of the respondents who suffer MS aged between 25-35, (84.9%) of the respondents who suffer MS are Saudi national, and (39.6%) of the respondents who suffer MS live in the Objectives:-Central region, as (73.6%) of the respondents who suffer MS hold a university degree. The analysis illustrated that (64.2%) of the respondents who suffer from MS don't have relatives suffer from MS, and (33. ISSN: 2320-5407Int. J. Adv. Res. 4(12), 1581-1600 1582 (83.0%) of the respondents who suffer from MS don't suffer from immune diseases, and (22.2 %) of the respondents who suffer from MS and immune diseases suffer from rhumatic fever or erthymatosis, as (96.2%) of the respondents who suffer from MS don't suffer from Genetic disease, and (50%) of the respondents who suffer from MS and Genetics disease suffer from diabetes or hypertension. The results of analysis illustrated that there were statistically significant differences between those with and without MS as regard to age, nationality and the region (P<0.05), while there were no statistically significant differences as regard to gender, education and marital status(P>0.05). Also, MS was more prevalent between 25 and 30 years (49.1%), in Saudi nation (84.9%) and the central region (39.6%). Also, there were statistically significant differences at the level of significance (P <0.05), in the prevalence of MS in the relatives of the patients with and without MS in favor of no prevalence of MS in the relatives of (64.1%) patients with and without of respondents, We found that there were statistically significant differences between those with and without MS as regard to absence of suspicious symptoms of MS of Weakness in arm or leg, Loss of Balance and Anxiety (P<0.05), while there were no statistically sign...

show abstract

Section: Discussionmentioning

confidence: 76%

Section: Discussionmentioning

confidence: 76%

See 1 more Smart Citation

Prevalence of Multiple Sclerosis in Saudi Arabia

Alshanqiti¹,

Alotaibi²,

Alahmed³

et al. 2016

IJAR

View full text Add to dashboard Cite

show abstract

“…The authors also intend to provide an update on the MS prevalence in Norway, compared to the first nationwide prevalence study published in 2014 2. Grytten et al estimate a nationwide prevalence of MS in Norway of 208 per 100,000 on 31 December 2013, which is not far from our reported 203 per 100,000 on 1 January 2012 (although confidence intervals were not given for the newly estimated 2013 data in the review article).…”

Section: A Step Back For Ms Prevalence Studies In Norwaymentioning

confidence: 91%

Comments on the review article ‘Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades’

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Forekomsten av multippel sklerose er økende, og det er beregnet at om lag 10 000 mennesker i Norge har sykdommen (1). Multippel sklerose reduserer livslengden med 5 -10 år og er en hyppig årsak til nevrologisk invaliditet.…”

unclassified